Certara (CERT) IPO Opens 30% Higher

Today's IPO for Certara, Inc. (NASDAQ: CERT) opened for trading $29.90 after pricing 29,055,000 shares of its common stock at $23.00 per share. Certara is offering 14,630,000 shares of its common stock and certain selling stockholders are offering 14,425,000 shares of common stock in the offering.

The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4,358,250 shares of common stock at the initial public offering price less the underwriting discounts and commissions.

The offering is being made through an underwriting group led by Jefferies, Morgan Stanley and BofA Securities, who are acting as lead joint book-running managers, and Credit Suisse, Barclays and William Blair, who are acting as joint book-running managers.

Certara, a global leader in biosimulation based on 2019 revenue, accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.

You May Also Be Interested In